1.
Change of initial oral antidiabetic therapy in type 2 diabetic patients
2.
IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings
The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: The Rotterdam study
Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study
Yield of opportunistic targeted screening for type 2 diabetes in primary care: The Diabscreen study